GERN Q1 2025 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$40M+12927.3% YoY

Gross Profit

$38M97.0% margin

Operating Income

-$17M-42.2% margin

Net Income

-$20M-50.1% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

-16.7%

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$48M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$562M

Total Liabilities

$294M

Stockholders' Equity

$268M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$304,000	+12927.3%
Gross Profit	$38M	$304,000	+12530.6%
Operating Income	-$17M	-$56M	+70.2%
Net Income	-$20M	-$55M	+64.2%

Revenue Segments

Revenues Before Adjustments

$45M53%

Product

$39M47%